Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Oliver

Showing results (881-890 of 912) with videos related to

Pageof 92
Sort By:
Cancer|September 5, 2019
Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancerCelestia S Higano, Andrew J Armstrong, A Oliver Sartor, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|June 11, 2015
Synthesis and summary of patient-reported outcome measures to inform the development of a core outcome set in colorectal cancer surgeryA G K McNair, R N Whistance, R O Forsythe, et al.
Molecular Therapy. Nucleic Acids|April 21, 2025
Splicing correction by peptide-conjugated morpholinos as a novel treatment for late-onset Pompe diseaseRyan A Oliver, Meghan E Ahern, Perla G Castaneda, et al.
The Journal of Hospital Infection|June 30, 2024
Risk factors and clinical impact of multidrug resistance in healthcare-associated bacteraemic urinary tract infections: a post-hoc analysis of a multicentre prospective cohort in SpainS Gómez-Zorrilla, F Becerra-Aparicio, E Sendra, et al.
Journal of the American Society of Nephrology : JASN|December 29, 2016
Unique Transcriptional Programs Identify Subtypes of AKIKatherine Xu, Paul Rosenstiel, Neal Paragas, et al.
European Urology|March 18, 2014
Effects of cabozantinib on pain and narcotic use in patients with castration-resistant prostate cancer: results from a phase 2 nonrandomized expansion cohortEthan Basch, Karen A Autio, Matthew R Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2023
An expandable, modular de novo protein platform for precision redox engineeringGeorge H Hutchins, Claire E M Noble, H Adrian Bunzel, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|July 19, 2003
Nanoscale solid-state quantum computingA Ardavan, M Austwick, S C Benjamin, et al.
Journal of Leukocyte Biology|October 1, 2024
Immunoresponsive gene 1 facilitates TLR4 agonist-induced augmentation of innate antimicrobial immunityMargaret A McBride, Katherine R Caja, Tazeen K Patil, et al.
European Urology Oncology|July 17, 2025
Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 TrialRyan M Phillips, James A Proudfoot, Elai Davicioni, et al.
Pageof 92

Showing results (881-890 of 912) with videos related to

Sort By:
Pageof 92
Cancer|September 5, 2019
Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancerCelestia S Higano, Andrew J Armstrong, A Oliver Sartor, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|June 11, 2015
Synthesis and summary of patient-reported outcome measures to inform the development of a core outcome set in colorectal cancer surgeryA G K McNair, R N Whistance, R O Forsythe, et al.
Molecular Therapy. Nucleic Acids|April 21, 2025
Splicing correction by peptide-conjugated morpholinos as a novel treatment for late-onset Pompe diseaseRyan A Oliver, Meghan E Ahern, Perla G Castaneda, et al.
The Journal of Hospital Infection|June 30, 2024
Risk factors and clinical impact of multidrug resistance in healthcare-associated bacteraemic urinary tract infections: a post-hoc analysis of a multicentre prospective cohort in SpainS Gómez-Zorrilla, F Becerra-Aparicio, E Sendra, et al.
Journal of the American Society of Nephrology : JASN|December 29, 2016
Unique Transcriptional Programs Identify Subtypes of AKIKatherine Xu, Paul Rosenstiel, Neal Paragas, et al.
European Urology|March 18, 2014
Effects of cabozantinib on pain and narcotic use in patients with castration-resistant prostate cancer: results from a phase 2 nonrandomized expansion cohortEthan Basch, Karen A Autio, Matthew R Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2023
An expandable, modular de novo protein platform for precision redox engineeringGeorge H Hutchins, Claire E M Noble, H Adrian Bunzel, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|July 19, 2003
Nanoscale solid-state quantum computingA Ardavan, M Austwick, S C Benjamin, et al.
Journal of Leukocyte Biology|October 1, 2024
Immunoresponsive gene 1 facilitates TLR4 agonist-induced augmentation of innate antimicrobial immunityMargaret A McBride, Katherine R Caja, Tazeen K Patil, et al.
European Urology Oncology|July 17, 2025
Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 TrialRyan M Phillips, James A Proudfoot, Elai Davicioni, et al.
Pageof 92